The Tree of Life, Kenrokuen Gaden, Kanazawa

We can easily imagine a ‘tree of life’ metaphor to illustrate the philosophical idea of how advancements in cancer therapeutics can represent a growing, intricate system with many branches.

While these branches – representing novel therapies – can offer hope and potential for improved outcomes, the complexity and resource requirements might not reach all branches of the population equally.

Increasingly there is disparity between those who benefit from cutting edge treatments and those who, due to geographic or systemic barriers, remain underserved.

In today’s post from the annual meeting of the European Society of Medical Oncology (ESMO), we highlight a couple of developments where the results might factually be considered practice changing owing to improvements in outcomes, yet for various reasons may not actually move the needle in the real world…

To learn more from our latest oncology review and get a heads up on key cancer research insights, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers

Posted by